WHO ICTRP trial
A study in healthy men to compare the amount of vicadrostat and empagliflozin in…
CTIS2024-518103-21-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-518103-21-00 |
|---|---|
| Public title | A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together |
| Scientific title | - 1378-0024 |
| Primary sponsor | Boehringer Ingelheim International GmbH |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Germany |
| Conditions | Healthy volunteer trial;Therapeutic area: Not possible to specify |
| Registration date | Mar 17, 2025 |
| Target size | 15 |
| Secondary IDs | U1111-1313-3279 |
| Registry page | euclinicaltrials.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: